6-131847856-GGTGTGTGTGTGTGTGTGTGTGTGTGT-GGTGTGTGTGTGTGTGTGT
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP6_Moderate
The NM_006208.3(ENPP1):c.313+39_313+46del variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000459 in 1,181,894 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00044 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00046 ( 0 hom. )
Consequence
ENPP1
NM_006208.3 intron
NM_006208.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.721
Genes affected
ENPP1 (HGNC:3356): (ectonucleotide pyrophosphatase/phosphodiesterase 1) This gene is a member of the ecto-nucleotide pyrophosphatase/phosphodiesterase (ENPP) family. The encoded protein is a type II transmembrane glycoprotein comprising two identical disulfide-bonded subunits. This protein has broad specificity and cleaves a variety of substrates, including phosphodiester bonds of nucleotides and nucleotide sugars and pyrophosphate bonds of nucleotides and nucleotide sugars. This protein may function to hydrolyze nucleoside 5' triphosphates to their corresponding monophosphates and may also hydrolyze diadenosine polyphosphates. Mutations in this gene have been associated with 'idiopathic' infantile arterial calcification, ossification of the posterior longitudinal ligament of the spine (OPLL), and insulin resistance. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP6
Variant 6-131847856-GGTGTGTGT-G is Benign according to our data. Variant chr6-131847856-GGTGTGTGT-G is described in ClinVar as [Likely_benign]. Clinvar id is 1114458.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ENPP1 | NM_006208.3 | c.313+39_313+46del | intron_variant | ENST00000647893.1 | NP_006199.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENPP1 | ENST00000647893.1 | c.313+39_313+46del | intron_variant | NM_006208.3 | ENSP00000498074 | P1 | ||||
ENPP1 | ENST00000513998.5 | c.313+39_313+46del | intron_variant, NMD_transcript_variant | 5 | ENSP00000422424 | |||||
ENPP1 | ENST00000650507.1 | c.*149+39_*149+46del | intron_variant, NMD_transcript_variant | ENSP00000497375 | ||||||
ENPP1 | ENST00000486853.1 | n.333+39_333+46del | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000430 AC: 59AN: 137174Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
59
AN:
137174
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000461 AC: 482AN: 1044632Hom.: 0 AF XY: 0.000393 AC XY: 208AN XY: 529460
GnomAD4 exome
AF:
AC:
482
AN:
1044632
Hom.:
AF XY:
AC XY:
208
AN XY:
529460
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000437 AC: 60AN: 137262Hom.: 0 Cov.: 0 AF XY: 0.000464 AC XY: 31AN XY: 66774
GnomAD4 genome
AF:
AC:
60
AN:
137262
Hom.:
Cov.:
0
AF XY:
AC XY:
31
AN XY:
66774
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 29, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at